{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T05:10:26Z","timestamp":1780549826675,"version":"3.54.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,19]],"date-time":"2017-02-19T00:00:00Z","timestamp":1487462400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Brasileira de Reumatologia (English Edition)"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.rbre.2017.02.002","type":"journal-article","created":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T08:47:54Z","timestamp":1490258874000},"page":"535-544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical outcomes and survival in AA amyloidosis patients"],"prefix":"10.1016","volume":"57","author":[{"given":"Yavuz","family":"Ayar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alparslan","family":"Ersoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa Ferhat","family":"Oksuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokhan","family":"Ocakoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berna Aytac","family":"Vuruskan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abd\u00fclmecit","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emel","family":"Isiktas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayseg\u00fcl","family":"Oruc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sedat","family":"Celikci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet Bilgehan","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"G\u00fcll\u00fcl\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbre.2017.02.002_bib0215","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.path.2014.04.006","article-title":"Renal amyloidosis","volume":"7","author":"Mohamed","year":"2014","journal-title":"Surg Pathol Clin"},{"key":"10.1016\/j.rbre.2017.02.002_bib0220","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2147\/CLEP.S39981","article-title":"Systemic AA amyloidosis: epidemiology, diagnosis, and management","volume":"6","author":"Real de As\u00faa","year":"2014","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.rbre.2017.02.002_bib0225","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-pathol-020712-163913","article-title":"AA amyloidosis: pathogenesis and targeted therapy","volume":"10","author":"Westermark","year":"2015","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.rbre.2017.02.002_bib0230","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.virusres.2014.12.019","article-title":"Systemic AA amyloidosis as a prion-like disorder","volume":"207","author":"Murakami","year":"2015","journal-title":"Virus Res"},{"key":"10.1016\/j.rbre.2017.02.002_bib0235","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/ckj\/sfu021","article-title":"Amyloid nephropathy","volume":"7","author":"Khalighi","year":"2014","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.rbre.2017.02.002_bib0240","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000444206","article-title":"The prevalence and management of systemic amyloidosis in Western countries","volume":"2","author":"Nienhuis","year":"2016","journal-title":"Kidney Dis (Basel)"},{"key":"10.1016\/j.rbre.2017.02.002_bib0245","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/ndt\/17.9.1594","article-title":"Spanish registry of glomerulonephritis frequency of renal pathology in Spain 1994\u20131999","volume":"17","author":"Rivera","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.rbre.2017.02.002_bib0250","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.2215\/CJN.10491012","article-title":"Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases","volume":"8","author":"Said","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.rbre.2017.02.002_bib0255","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1097\/PAS.0b013e3181abdfa7","article-title":"Prevalence and origin of amyloid in kidney biopsies","volume":"33","author":"von Hutten","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.rbre.2017.02.002_bib0260","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/978-94-007-5416-4_20","article-title":"Systemic AA amyloidosis","volume":"65","author":"Pinney","year":"2012","journal-title":"Subcell Biochem"},{"key":"10.1016\/j.rbre.2017.02.002_bib0265","doi-asserted-by":"crossref","first-page":"229","DOI":"10.5414\/CN107151","article-title":"AA amyloid nephropathy with predominant vascular deposition in Crohn's disease","volume":"79","author":"Kurita","year":"2013","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.rbre.2017.02.002_bib0270","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000343398","article-title":"Renal involvement in AA amyloidosis: clinical outcomes and survival","volume":"37","author":"Yilmaz","year":"2013","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.rbre.2017.02.002_bib0275","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/qjmed\/93.8.535","article-title":"Presentation, survival and prognostic markers in AA amyloidosis","volume":"93","author":"Joss","year":"2000","journal-title":"QJM"},{"key":"10.1016\/j.rbre.2017.02.002_bib0280","doi-asserted-by":"crossref","first-page":"950","DOI":"10.4103\/1319-2442.118094","article-title":"Incidence and clinical outcome of renal amyloidosis: a retrospective study","volume":"24","author":"Abdallah","year":"2013","journal-title":"Saudi J Kidney Dis Transplant"},{"key":"10.1016\/j.rbre.2017.02.002_bib0285","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.autrev.2014.01.045","article-title":"Diagnostic criteria of familial Mediterranean fever","volume":"13","author":"Berkun","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.rbre.2017.02.002_bib0290","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.rbre.2017.02.002_bib0295","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/003655902762467602","article-title":"Long-term effects of losartan on proteinuria and renal function in patients with renal amyloidosis","volume":"36","author":"Dilek","year":"2002","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.rbre.2017.02.002_bib0300","doi-asserted-by":"crossref","first-page":"68","DOI":"10.5262\/tndt.2015.1001.09","article-title":"The evaluation of amyloidosis cases with renal involvement: a single-center experience","volume":"24","author":"Ayar","year":"2015","journal-title":"Turk Nephrol Dial Transplant"},{"key":"10.1016\/j.rbre.2017.02.002_bib0305","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1093\/ndt\/gfh521","article-title":"The Czech registry of renal biopsies. Occurrence of renal diseases in the years 1994\u20132000","volume":"19","author":"Rychl\u00edk","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.rbre.2017.02.002_bib0310","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.2169\/internalmedicine.50.5822","article-title":"Clinical features of renal amyloidosis: an analysis of 40 patients in a 28-year follow-up","volume":"50","author":"Tsai","year":"2011","journal-title":"Intern Med"},{"key":"10.1016\/j.rbre.2017.02.002_bib0315","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s11255-009-9524-2","article-title":"Renal AA amyloidosis: survey of epidemiologic and laboratory data from one nephrology centre","volume":"41","author":"Potysov\u00e1","year":"2009","journal-title":"Int Urol Nephrol"},{"issue":"Suppl. 9","key":"10.1016\/j.rbre.2017.02.002_bib0320","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/ndt\/11.supp9.63","article-title":"Clinical and therapeutic aspects of renal amyloidosis","volume":"11","author":"Schena","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.rbre.2017.02.002_bib0325","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1186\/1471-2458-12-974","article-title":"Incidence and survival in non-hereditary amyloidosis in Sweden","volume":"12","author":"Hemminki","year":"2012","journal-title":"BMC Public Health"},{"key":"10.1016\/j.rbre.2017.02.002_bib0330","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1093\/ndt\/gfh890","article-title":"Clinicopathological and epidemiological analysis of amyloidosis in Turkish patients","volume":"20","author":"Ensari","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.rbre.2017.02.002_bib0335","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00005792-199107000-00002","article-title":"Secondary systemic amyloidosis: response and survival in 64 patients","volume":"70","author":"Gertz","year":"1991","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rbre.2017.02.002_bib0340","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1023\/A:1007152320216","article-title":"Report of 59 cases of renal amyloidosis","volume":"31","author":"Paydas","year":"1999","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.rbre.2017.02.002_bib0345","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.rce.2012.09.001","article-title":"Clinical characteristics of the patients with systemic amyloidosis in 2000\u20132010","volume":"213","author":"Real de As\u00faa","year":"2013","journal-title":"Rev Clin Esp (Barc)"},{"key":"10.1016\/j.rbre.2017.02.002_bib0350","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1093\/ndt\/17.11.2003","article-title":"A retrospective analysis for aetiology and clinical findings of 287 secondary amyloidosis cases in Turkey","volume":"17","author":"Tuglular","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.rbre.2017.02.002_bib0355","first-page":"421","article-title":"Familial Mediterranean fever \u2013 a review and update","volume":"92","author":"Orbach","year":"2001","journal-title":"Minerva Med"},{"key":"10.1016\/j.rbre.2017.02.002_bib0360","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.rbr.2015.09.006","article-title":"Investigation of MEFV gene polymorphisms (G138G and A165A) in adult patients with familial Mediterranean fever","volume":"57","author":"\u00d6ksuz","year":"2017","journal-title":"Rev Bras Reumatol"},{"key":"10.1016\/j.rbre.2017.02.002_bib0365","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMoa070265","article-title":"Natural history and outcome in systemic AA amyloidosis","volume":"356","author":"Lachmann","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rbre.2017.02.002_bib0370","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1093\/ndt\/gfq831","article-title":"Renal amyloidosis revisited: amyloid distribution, dynamics and biochemical type","volume":"26","author":"Hofer","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl. 1","key":"10.1016\/j.rbre.2017.02.002_bib0375","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3109\/13506129.2011.574354085","article-title":"The changing face of AA amyloidosis: a single center experience","volume":"18","author":"Girnius","year":"2011","journal-title":"Amyloid"},{"key":"10.1016\/j.rbre.2017.02.002_bib0380","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/msj.21342","article-title":"AA amyloidosis: Mount Sinai experience, 1997\u20132012","volume":"79","author":"Bunker","year":"2012","journal-title":"Mt Sinai J Med"},{"key":"10.1016\/j.rbre.2017.02.002_bib0385","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/eci.12157","article-title":"Decreasing incidence of AA amyloidosis in Spain","volume":"43","author":"Siddique","year":"2013","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.rbre.2017.02.002_bib0390","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/ndt\/gfm684","article-title":"Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome","volume":"23","author":"Bergesio","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.rbre.2017.02.002_bib0395","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/13506120701816777","article-title":"Spontaneous perirenal hematoma with AA amyloidosis in a hemodialysis patient after unilateral nephrectomy","volume":"15","author":"Kahvecioglu","year":"2008","journal-title":"Amyloid"},{"key":"10.1016\/j.rbre.2017.02.002_bib0400","first-page":"644","article-title":"Outcome of 121 patients with renal amyloid a amyloidosis","volume":"19","author":"Ahbap","year":"2014","journal-title":"J Res Med Sci"},{"key":"10.1016\/j.rbre.2017.02.002_bib0405","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbapap.2005.08.014","article-title":"Clinical aspects of systemic amyloid diseases","volume":"1753","author":"Obici","year":"2005","journal-title":"Biochim Biophys Acta (BBA) \u2013 Proteins Proteomics"},{"key":"10.1016\/j.rbre.2017.02.002_bib0410","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1742-1241.2002.tb11272.x","article-title":"Clinical and biochemical outcome of renal amyloidosis","volume":"56","author":"Odabas","year":"2002","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.rbre.2017.02.002_bib0415","first-page":"343","article-title":"Clinical outcome and survival of secondary (AA) amyloidosis","volume":"21","author":"Tanaka","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rbre.2017.02.002_bib0420","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0140-6736(00)05252-1","article-title":"Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein","volume":"358","author":"Gillmore","year":"2001","journal-title":"Lancet"}],"container-title":["Revista Brasileira de Reumatologia (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2255502117300111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2255502117300111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T19:43:47Z","timestamp":1692733427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2255502117300111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S2255502117300111"],"URL":"https:\/\/doi.org\/10.1016\/j.rbre.2017.02.002","relation":{},"ISSN":["2255-5021"],"issn-type":[{"value":"2255-5021","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical outcomes and survival in AA amyloidosis patients","name":"articletitle","label":"Article Title"},{"value":"Revista Brasileira de Reumatologia (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbre.2017.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rbr.2016.12.002","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Editora Ltda.","name":"copyright","label":"Copyright"}]}}